Summary

微RNA循环使用定量DNA结合染料化学和液滴的数字PCR

Published: June 26, 2016
doi:

Summary

A sensitive and accurate method for cell-free microRNAs quantification using a dye-based chemistry and droplet digital PCR technology is described.

Abstract

循环微RNA(miRNA)(无细胞的),从细胞释放到血流中。在循环的特定微小RNA的量已与一种疾病状态,并具有被用作疾病的生物标志物的潜力。用于使用基于染料的化学和液滴数字PCR技术循环微RNA定量的灵敏和准确的方法最近已开发。具体而言,使用锁核酸(LNA)为基础的miRNA特异性引物用绿色荧光DNA结合染料在相容的液滴数字PCR系统能够获得特定miRNA的绝对定量。在这里,我们描述了如何执行此技术,以评估在生物流体,例如血浆和血清的miRNA量,是可行和有效的。

Introduction

MicroRNAs (miRNAs) are released into blood circulation by potentially all the cells of the organism, as a consequence of active release or necrotic and apoptotic processes. Cell-free miRNAs have been detected in the bloodstream either as free stable molecules or linked to lipoproteins or enveloped inside exosomes and microvesicles 1-3. They are believed to function as cell-to-cell communicators 4, and their amount changes in the presence of cancer, cardiac disorders or autoimmune diseases 5-7. Their accurate and reproducible quantification is the basis for their evaluation as disease biomarkers. However, for several reasons already described elsewhere 8,9, miRNA quantification in serum or plasma, as well as other body fluids, could be very challenging 10,11. We recently developed a method for the absolute quantification of circulating miRNAs, based on miRNA-specific LNA primers and DNA-binding dye droplet digital PCR (ddPCR) technology 12. This methodology has been applied to the validation of miRNA breast cancer biomarkers 13,14.

After the partitioning of each reverse-transcribed miRNA molecule inside a nanoliter-sized droplet, it is possible to count the copy number of each miRNA in each sample, basically counting the number of green, and therefore positive, fluorescent droplets. As soon as a PCR reaction occurs, a positive count is achieved, without the need to establish a standard curve or taking PCR efficiency into account in target amount calculation, as it happens with quantitative RT-PCR (RT-qPCR). In addition, ddPCR proved to be more sensitive and accurate than RT-qPCR in circulating miRNA quantification 15. In this article we present the detailed protocol of this methodology, discussing the most relevant steps andspecifically considering serum and plasma clinical samples.

Protocol

从血浆或血清中分离的microRNA 注意:血浆和血清制剂是循环的miRNA定量的相关步骤。存在用于血浆和血清制备没有优选的程序。唯一要考虑的重要的事情是,所有来自同一实验的样品必须使用完全相同的工作流程进行处理。从200μl的血清或血浆开始。总RNA可以从血清或血浆用市售试剂盒进行分离。 1,协议总RNA(miRNA的包括)隔离在冰上解冻血清/血浆样本。 …

Representative Results

可使用绿色荧光DNA结合染料和液滴数字PCR技术来确定每毫升的血浆或血清的特定miRNA的绝对量。 图1表示正极的液滴选择的过程中,它决定了最终的miRNA浓度(拷贝/微升)在由分析软件计算的扩增反应。血液中的每个miRNA的量是非常不同的,是一些miRNA族比其他人更丰富。使用在ddPCR反应1:50稀释的cDNA,可以得到正和负的液滴的足够数量。在正液滴饱和( 例如…

Discussion

循环miRNA是存在于血液中的浓度极低,而且可以从血浆和血清样品中提取的RNA的量是低的。因为这个原因,它们难以与其它技术,如微阵列和RNA测序量化。此外,还有在数据归一化的一般化缺乏协议和内源性“参考”微RNA在血液中的存在。在这种情况下,一个灵敏的技术,如微滴数字PCR,能够每毫升血清或血浆,即使非常低的计数的miRNA拷贝数的,是非常有吸引力的。我们配对该技术具有普遍性的…

Disclosures

The authors have nothing to disclose.

Acknowledgements

从意大利癌症研究协会(AIRC)为MF(MFAG 11676)和MN资金支持(特别节目分子临床肿瘤学 – 5千分数ñ9980,2010/15)和指令意大利教育部,大学和研究FIRB 2011年明尼苏达州(项目RBAPIIBYNP)。

Materials

miRNeasy Mini Kit Qiagen 217004 Columns for total RNA, including miRNA, extraction from serum/plasma
100 nmole RNA oligo Cel-miR-39-3p Integrated DNA Technologies Custom Sequence: UCACCGGGUGUAAAUCAGCUUG
Universal cDNA synthesis kit II, 8-64 rxns Exiqon 203301 Kit for microRNA reverse transcription
MicroRNA LNA PCR primer set  Exiqon 204000-206xxx and 2100000-21xxxxx Primers for miRNA amplification inside droplets
QX200 droplet generator BioRad 186-4002 Instrument used for droplet reading
QX200 droplet reader BioRad 186-4003 Instrument used for droplet generation
QuantaSoft software BioRad 186-3007 Software for data collection and analysis
PX1 PCR plate sealer BioRad 181-4000 Plate sealer
DG8 droplet generator cartridges and gaskets BioRad 186-4008 Cartridges used to mix sample and oil to generate droplets
QX200 ddPCR EvaGreen supermix BioRad 186-4033/36 PCR supermix
QX200 droplet generator oil for EvaGreen dye BioRad 186-4005 Oil for droplet generation

References

  1. Arroyo, J. D., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 108, 5003-5008 (2011).
  2. Skog, J., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 10, 1470-1476 (2008).
  3. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 13, 423-433 (2011).
  4. Braicu, C., et al. Exosomes as divine messengers: are they the Hermes of modern molecular oncology. Cell Death Differ. 22, 34-45 (2015).
  5. Creemers, E. E., Tijsen, A. J., Pinto, Y. M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease. Circ Res. 110, 483-495 (2012).
  6. Guay, C., Regazzi, R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol. 9, 513-521 (2013).
  7. Schwarzenbach, H., Nishida, N., Calin, G. A., Pantel, K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 11, 145-156 (2014).
  8. Moldovan, L., et al. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 18, 371-390 (2014).
  9. Tiberio, P., Callari, M., Angeloni, V., Daidone, M. G., Appierto, V. Challenges in Using Circulating miRNAs as Cancer Biomarkers. Biomed Res Int. 2015, 731479 (2015).
  10. Jarry, J., Schadendorf, D., Greenwood, C., Spatz, A., van Kempen, L. C. The validity of circulating microRNAs in oncology: five years of challenges and contradictions. Mol Oncol. 8, 819-829 (2014).
  11. Witwer, K. W. Circulating MicroRNA Biomarker Studies: Pitfalls and Potential Solutions. Clin Chem. 61, 56-63 (2015).
  12. Miotto, E., et al. Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries. Cancer Epidemiol Biomarkers Prev. 23, 2638-2642 (2014).
  13. Ferracin, M., et al. Absolute quantification of cell-free microRNAs in cancer patients. Oncotarget. , (2015).
  14. Mangolini, A., et al. Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR. Biomarker Research. , (2015).
  15. Hindson, C. M., et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods. 10, 1003-1005 (2013).
  16. Mestdagh, P., et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 11, 809-815 (2014).

Play Video

Cite This Article
Ferracin, M., Salamon, I., Lupini, L., Miotto, E., Sabbioni, S., Negrini, M. Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR. J. Vis. Exp. (112), e54102, doi:10.3791/54102 (2016).

View Video